Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. [electronic resource]
Producer: 20070813Description: 707-12 p. digitalISSN:- 0275-004X
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- diagnosis
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fovea Centralis
- Humans
- Injections
- Male
- Middle Aged
- Myopia, Degenerative -- complications
- Prospective Studies
- Retina -- drug effects
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- drug effects
- Vitreous Body
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.